| 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology … AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ... European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022 | 1180 | 2022 |
| Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the C … AR Lyon, S Dent, S Stanway, H Earl, C Brezden‐Masley, A Cohen‐Solal, ... European journal of heart failure 22 (11), 1945-1960, 2020 | 510 | 2020 |
| Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the H eart F ailure A ssociation (HFA), the E uropean A … J Čelutkienė, R Pudil, T López‐Fernández, J Grapsa, P Nihoyannopoulos, ... European journal of heart failure 22 (9), 1504-1524, 2020 | 323 | 2020 |
| Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association … R Pudil, C Mueller, J Čelutkienė, PA Henriksen, D Lenihan, S Dent, ... European journal of heart failure 22 (11), 1966-1983, 2020 | 254 | 2020 |
| Clopidogrel pre-treatment in stable angina: for all patients> 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI … P Widimský, Z Motovska, S Šimek, P Kala, R Pudil, F Holm, R Petr, ... European heart journal 29 (12), 1495-1503, 2008 | 160 | 2008 |
| Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge P Ameri, M Canepa, MS Anker, Y Belenkov, J Bergler‐Klein, ... European journal of heart failure 20 (5), 879-887, 2018 | 150 | 2018 |
| Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the … RA de Boer, JS Hulot, CG Tocchetti, JP Aboumsallem, P Ameri, SD Anker, ... European journal of heart failure 22 (12), 2272-2289, 2020 | 113 | 2020 |
| Cytokines and adhesion molecules in the course of acute myocardial infarction R Pudil, V Pidrman, J Krejsek, J Gregor, M Tichý, C Andrýs, M Drahošová Clinica chimica acta 280 (1-2), 127-134, 1999 | 88 | 1999 |
| Application of proteomics in biomarker discovery: a primer for the clinician. V Tambor, A Fučíková, J Lenčo, M Kacerovský, V Řeháček, J Stulik, ... Physiological Research 59 (4), 2010 | 86 | 2010 |
| Assessment of anthracycline-induced cardiotoxicity with electrocardiography JM Horacek, M Jakl, J Horackova, R Pudil, L Jebavy, J Maly Experimental oncology, 2009 | 77 | 2009 |
| Assessment of anthracycline-induced cardiotoxicity with biochemical markers JM Horacek, R Pudil, L Jebavy, M Tichy, P Zak, J Maly Exp Oncol 29 (4), 309-13, 2007 | 75 | 2007 |
| Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology. Cancer diagnosis in patients with heart failure: epidemiology, clinical … P Ameri, M Canepa, MS Anker, Y Belenkov, J Bergler-Klein, ... Eur J Heart Fail 20 (5), 879-887, 2018 | 63 | 2018 |
| Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study. An … P Tousek, R Rokyta, J Tesarova, R Pudil, J Belohlavek, J Stasek, F Rohac, ... Acute Cardiac Care 13 (3), 116-122, 2011 | 62 | 2011 |
| Monitoring of the very early changes of left ventricular diastolic function in patients with acute leukemia treated with anthracyclines R Pudil, JM Horacek, A Strasova, L Jebavy, J Vojacek Experimental Oncology, 2008 | 53 | 2008 |
| The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia JM Horacek, M Vasatova, M Tichy, R Pudil, L Jebavy, J Maly Experimental oncology, 2010 | 51 | 2010 |
| The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia. JM Horacek, R Pudil, M Tichý, L Jebavý, A Strasova, R Praus, P Zak, ... Neoplasma 52 (5), 430-434, 2005 | 51 | 2005 |
| Severe bradycardia after a methylprednisolone minipulse treatment R Pudil, Z Hrncir Archives of Internal Medicine 161 (14), 1778-1779, 2001 | 44 | 2001 |
| Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’ MS Anker, S Hadzibegovic, A Lena, Y Belenkov, J Bergler‐Klein, ... ESC heart failure 6 (6), 1140-1148, 2019 | 41 | 2019 |
| Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity JM Horacek, M Tichy, R Pudil, L Jebavy Annals of oncology 19 (9), 1656-1657, 2008 | 41 | 2008 |
| Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia JM Horacek, R Pudil, M Tichy, L Jebavy, P Zak, L Slovacek, J Maly Experimental oncology, 2007 | 39 | 2007 |
